As the cannabidiol (CBD) from hemp market continues to entice cannabis companies, a new partnership for this market was created between two public players in the space.

Invictus MD Strategies (TSXV:GENE), an owner of a Canadian licensed producer, confirmed on Monday (January 7) it will form a joint venture with relatively newcomer CannAmerica Brands (CSE:CANA), a cannabis brands company pursuing the US market.


The two will create this new venture alongside CBDistribution Company (CBDC).

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

According to the details of the partnership, Invictus will provide a C$5 million credit set to be used as the funding for working capital and operations.

George Kveton, CEO of Invictus, said this new partnership will offer his company a chance to expand beyond the Canadian cannabis market.

CannAmerica is set to participate in the extraction and post processing segment of the production with expertise on dosing and the formulation of concentrates.

“[CannAmerica] will contribute operational expertise, will source the property, extraction equipment, staffing and manage operations,” said the company. “CBDC will contribute the sourcing of Hemp Biomass procurement, branding, marketing and the commercialization of the finished product, including but not limited to CBD Isolate.”

This move is boosted by the signing of a new US$867 farm bill that legalized the hemp industry in the US. Cannabis companies are starting to target the CBD derived from hemp market thanks to this new bill.

A CNBC report indicated the approval of this bill could create a US$20 billion industry by 2022.

Dan Anglin, CEO and co-founder of CannAmerica, said this move accelerates the timetable for his company to come into the CBD-derived from hemp market in the US.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

CannAmerica went public on the Canadian Securities Exchange in October; since then, the share price of the company has declined 17.65 percent.

Following Monday’s announcement, the market deemed the move favorable for Invictus, which saw its stock raise in value 7.14 percent. Shares finished the day at a price of [C$price].

However, CannAmerica declined sharply during the trading session by 10.71 percent to a price of C$0.75.

The passing of the farm bill has opened the floodgates for companies in the space to set out roadmaps for plans in this emerging marketplace.

“There is no bigger event than this for the CBD industry,” Michael Yorke, CEO of CROP Infrastructure (CSE:CROP), said in a statement to shareholders.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Invictus MD Strategies is a client of the Investing News Network. This article is not paid-for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (“ Avicanna ” or the “ Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces that Janet Giesselman has resigned from her role as an independent director of the Company to pursue other opportunities.

Keep reading... Show less

A renowned global bank with wealth management options has elected to block some cannabis trades from clients as part of its de-risking efforts after recent issues.

Also this week, a Canadian cannabis producer announced its intention to buy a retail operator managing nearly 100 stores in the country.

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) ( CSE: HARV OTCQX: HRVSF ), a vertically integrated cannabis company and multi-state operator in the U.S., today announced a settlement agreement has been reached for Agrimed Industries of PA, LLC (“AGRiMED”). The membership interests of AGRiMED are owned by Harvest Health and Recreation Inc.

Keep reading... Show less

Receives processing license for the commercial production and sale of cannabinoids using biosynthesis

Announces plans to launch Spinach™ branded edibles to the Canadian adult-use market

Keep reading... Show less